Ausgabe 5/2024
Inhalt (9 Artikel)
Commentary
Economic Evaluations of Treatments for Duchenne Muscular Dystrophy: The Caregiver QALY Trap
Erik Landfeldt, Hera Sandhu
Open Access
Practical Application
Value of Information for Clinical Trial Design: The Importance of Considering All Relevant Comparators
Anna Heath, Gianluca Baio, Ioanna Manolopoulou, Nicky J. Welton
Review Article
Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments
Jen-Yu Amy Chang, James B. Chilcott, Nicholas R. Latimer
Open Access
Systematic Review
Content Comparison of Quality-of-Life Instruments Used in Economic Evaluations of Sleep Disorder Interventions: A Systematic Review
Billingsley Kaambwa, Taylor-Jade Woods, Andrea Natsky, Norma Bulamu, Christine Mpundu-Kaambwa, Kelly A. Loffler, Alexander Sweetman, Peter G. Catcheside, Amy C. Reynolds, Robert Adams, Danny J. Eckert
Open Access
Systematic Review
Critical Examination of Modeling Approaches Used in Economic Evaluations of First-Line Treatments for Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations: A Systematic Literature Review
Angie Raad, Maria Rizzo, Katherine Appiah, Isabella Kearns, Luis Hernandez
Open Access
Original Research Article
Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy in the USA
Shih-Wen Lin, Sheila Shapouri, Hélène Parisé, Eric Bercaw, Mei Wu, Eunice Kim, Matthew Matasar
Open Access
Original Research Article
Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary
Anna Nikl, Mathieu F. Janssen, Balázs Jenei, Valentin Brodszky, Fanni Rencz